Market Research Logo

Global Generic Oncology Sterile Injectable Market By Product Type, By Disease Indication, By Distribution Channel, and By Region - Trends and Forecast till 2015

Global Generic Oncology Sterile Injectable Market By Product Type, By Disease Indication, By Distribution Channel, and By Region - Trends and Forecast till 2015

Generic oncology sterile injectables are used in treatment of various types of cancers such as ovarian, breast, and lung. These drugs are relatively cheaper than branded counterparts. This is owing presence of same active ingredients, although its inactive contents are different. Cost is a major concern for cancer patients, especially in emerging economies such as India, Brazil, and China. Therefore, governments of such countries are taking efforts to reduce cost of medications and increase its accessibility. For instance, the National Pharmaceutical Pricing Authority (NPPA) of India reduced the prices of a few cancer drugs by 86% in March 2017. Generic oncology sterile injectables have a huge potential in such countries, where patient population is high; however, spending power is relatively low. Furthermore, patent expiry is expected to fuel growth of the generic oncology sterile injectables during the forecast period. Also, the emergence of biosimilars has also impacted growth of generics drugs. For instance, according to the Journal of Generics and Biosimilars Initiative, 2017, biosimilars had a major share in Europe since 2013 and in the U.S. since 2015 and the share of biosimilars is expected to increase significantly in the biologicals market. This is expected to eventually boost growth of the generic oncology sterile injectable market.
Market Dynamics
Generic oncology sterile injectables market is gaining significant traction due to rising prevalence of cancer cases. For instance, according to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancers were reported in the U.S. Manufacturers are focusing on launching new products to offer low cost treatment to patients. For instance, in November, 2017, Mylan N.V. launched Clofarabine Injection (20 mg/20 mL (1 mg/mL) Single-Dose Vials) following U.S. Food and Drug administration approval in the U.S. market.  Clofarabine is a generic version of Genzyme's Clolar, which is used for treatment of refractory acute lymphoblastic leukemia for patients aged 1 year to 21 years.
Key features of the study:

This report provides in-depth analysis of the generic oncology sterile injectables market and its product type, market size (US$ Million), and Cumulative Annual Growth Rate (CAGR %) for the forecast period: 2017 – 2025, considering 2016as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
It profiles leading players in the generic oncology sterile injectables market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.
Key companies covered as a part of this study include Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, distribution channel, market expansion, and marketing tactics.
The generic oncology sterile injectables market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for generic oncology sterile injectables market, research and consulting firms, new entrants and financial analysts.
Various strategy matrices used in analyzing the generic oncology sterile injectables market would provide stakeholders vital inputs to make strategic decisions accordingly.

Detailed Segmentation:

Global Generic Oncology Sterile Injectable Market, By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

Global Generic Oncology Sterile Injectable Market, By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

Global Generic Oncology Sterile Injectable Market, By Distribution Channel :

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Generic Oncology Sterile Injectable Market, By Regions :

North America

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

U.S.
Canada

Latin America

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Brazil
Mexico
Rest of Latin America

Europe

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product Type:

Chemotherapy

Alkylating agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others

Monoclonal Antibodies
Cytokines
Peptide Hormones

By Disease Indication:

Ovarian Cancer
Breast Cancer
Lung Cancer
Pancreatic Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

South Africa
Central Africa
North Africa

Company Profiles

Eli Lilly & Company*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Biocon Ltd.
Baxter International Inc.
Hikma Pharmaceuticals PLC
Mylan N.V.
Sandoz International GmbH
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.

“*” marked represents similar segmentation in other categories in the respective section


Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Disease Indication
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Industry Trend
Merger and Acquisitions
New Product Approvals/Launch
Promotion and Marketing Initiatives
Global Generic Oncology Sterile Injectable Market, By Product Type, 2017 - 2025 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2015 - 2025
Segment Trends
Chemotherapy
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Alkylating agents
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Antimetabolites
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Plant Alkaloids
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Antitumor Antibiotics
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Cytokines
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Peptide Hormones
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Global Generic Oncology Sterile Injectable Market, By Disease Indication, 2017 - 2025 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2015 - 2025
Segment Trends
Ovarian Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Breast Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Lung Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Pancreatic Cancer
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Global Generic Oncology Sterile Injectable Market, By Distribution Channel, 2017 - 2025 (US$ Million)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2015 - 2025
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
Global Generic Oncology Sterile Injectable Market, By Regions, 2017 - 2025 (US$ Million)
Introduction
Market Share Analysis, By Region, 2017 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2015 – 2025
Regional Trends
North America
Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
Brazil
Mexico
Rest of Latin America
Europe
Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
South Africa
Central Africa
North Africa
Competitive Landscape
Heat Map Analysis
Company Profiles
Eli Lilly & Company
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Biocon Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Baxter International Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Hikma Pharmaceuticals PLC
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Mylan N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Sandoz International GmbH
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Pfizer Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Section
References
Research Methodology
About us and Sales Contact
*Browse 28 market data tables and 25 figures on "Generic Oncology Sterile Injectable Market” - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report